Semaglutide injections like Ozempic or Wegovy are GLP-1 agonists, meaning they work by mimicking the GLP-1, a naturally occurring hormone produced in the intestines after eating to regulate blood sugar levels and communicate satiety
The GIP component is what distinguishes tirzepatide from semaglutide and its presence in retatrutide but absence in survodutide creates a natural experiment for evaluating GIPs contribution to weight loss outcomes
[DOI] [PubMed] [Google Scholar] 52.Granado-Serrano AB, Martin MA, Haegeman G, Goya L, Bravo L, Ramos S
Instead, theyre often tied to: Shifts in eating or activity routines Initial digestive discomfort Lifestyle habits Dr
Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old glucose-intolerant rats
Diabetes Care 39 , 14931500 (2016)